Dizal (Jiangsu) Pharmaceutical Co. Ltd.SSE: 688192

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Dizal (Jiangsu) Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE ·

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-859

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix

Earlier from Dizal (Jiangsu) Pharmaceutical

Later from Dizal (Jiangsu) Pharmaceutical

All Dizal (Jiangsu) Pharmaceutical news releases